Correlation Between Tarsus Pharmaceuticals and Connecticut Light
Can any of the company-specific risk be diversified away by investing in both Tarsus Pharmaceuticals and Connecticut Light at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tarsus Pharmaceuticals and Connecticut Light into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tarsus Pharmaceuticals and The Connecticut Light, you can compare the effects of market volatilities on Tarsus Pharmaceuticals and Connecticut Light and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tarsus Pharmaceuticals with a short position of Connecticut Light. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tarsus Pharmaceuticals and Connecticut Light.
Diversification Opportunities for Tarsus Pharmaceuticals and Connecticut Light
-0.58 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Tarsus and Connecticut is -0.58. Overlapping area represents the amount of risk that can be diversified away by holding Tarsus Pharmaceuticals and The Connecticut Light in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Connecticut Light and Tarsus Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tarsus Pharmaceuticals are associated (or correlated) with Connecticut Light. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Connecticut Light has no effect on the direction of Tarsus Pharmaceuticals i.e., Tarsus Pharmaceuticals and Connecticut Light go up and down completely randomly.
Pair Corralation between Tarsus Pharmaceuticals and Connecticut Light
Given the investment horizon of 90 days Tarsus Pharmaceuticals is expected to generate 5.12 times more return on investment than Connecticut Light. However, Tarsus Pharmaceuticals is 5.12 times more volatile than The Connecticut Light. It trades about 0.12 of its potential returns per unit of risk. The Connecticut Light is currently generating about 0.1 per unit of risk. If you would invest 4,908 in Tarsus Pharmaceuticals on September 12, 2024 and sell it today you would earn a total of 306.00 from holding Tarsus Pharmaceuticals or generate 6.23% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Tarsus Pharmaceuticals vs. The Connecticut Light
Performance |
| Timeline |
| Tarsus Pharmaceuticals |
| Connecticut Light |
Tarsus Pharmaceuticals and Connecticut Light Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Tarsus Pharmaceuticals and Connecticut Light
The main advantage of trading using opposite Tarsus Pharmaceuticals and Connecticut Light positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tarsus Pharmaceuticals position performs unexpectedly, Connecticut Light can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Connecticut Light will offset losses from the drop in Connecticut Light's long position.| Tarsus Pharmaceuticals vs. Equillium | Tarsus Pharmaceuticals vs. DiaMedica Therapeutics | Tarsus Pharmaceuticals vs. Valneva SE ADR | Tarsus Pharmaceuticals vs. Vivani Medical |
| Connecticut Light vs. GMS Inc | Connecticut Light vs. Apogee Therapeutics, Common | Connecticut Light vs. Regeneron Pharmaceuticals | Connecticut Light vs. Tarsus Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Other Complementary Tools
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |